Protagenic Therapeutics, Inc.
PTIX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001022899
In the last 90 days, Protagenic Therapeutics, Inc. insiders filed 7 open-market purchases and 0 sales; 2 institutions reported holding it in 13F filings for Q2 2026, worth $25.4K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Protagenic Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 9 | 9 | 0 |
| Shares | 149.9K | 337.8K | +187.8K (+125.3%) |
| Value | $75.0K | $65.9K | −$9.11K (−12.1%) |
New holders (2)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 124,015 | $24.0K | 0.00% |
| Two Sigma Securities, LLC | 27,968 | $5.46K | 0.00% |
Sold out (2)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Advisor Group Holdings, Inc. | 21,414 | $10.5K |
| UBS Group AG | 14,414 | $7.06K |